Sanofi to test Parkinson`s drug with Michael J. Fox Foundation
Paris: French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson`s disease.
Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi`s AVE8112, a drug that has shown promise in preclinical tests as a therapy for some of the psychiatric symptoms of the disease.
Parkinson`s disease is a brain disorder that leads to shaking and difficulty with walking as well as mood changes and impaired memory.
All data and results generated by the clinical trial will be owned by MJFF and shared with Sanofi. Further development plans will be based on the results of the study, Sanofi said.
Patient enrollment in the study, which will be conducted in the U.S., is expected to begin later this year.
More from India
More from World
More from Sports
More from Entertaiment
- Indian- Americans launch online petition to declare Pakistan 'sponsor of terrorism'
- Panel discussion over PM Modi's willingness to engage in direct dialogue with Pak
- EU warns Pakistan of political and economic sanctions over atrocities in Baloch
- Should Pakistani artists be restricted from working in India?
- PM Modi slams Pakistan govt during his speech in Kozhikode
- SHOCKING VIDEO: This man was trying to take selfie with python - You won't believe what happened next!
- Call up this number and get Reliance Jio's SIM for sure
- WATCH: Ravichandran Ashwin's magic ball that bamboozled Kane Williamson on Day 3
- If you have guts, send your suicide bombers to Pakistan: Samajwadi Party to MNS' Raj Thackeray
- Govt calls meet on Indus Water Treaty; Water Resources Ministry, MEA to brief PM Modi